USANA Health Sciences Sees 8% Sales Growth to $925.3M, Guides $925M–$1B
USANA Health Sciences reported fiscal 2025 net sales of $925.3 million, up 8% year-over-year, driven by Hiya brand contribution and expanded omnichannel distribution. Fourth-quarter revenue rose 6% to $226.2 million with adjusted EPS of $0.60, and the company forecasts $925 million-$1 billion in sales for 2026.
1. Full-Year and Fourth-Quarter Results
USANA Health Sciences delivered fiscal 2025 net sales of $925.3 million, marking an 8% increase over the prior year. In the fourth quarter, revenue climbed 6% to $226.2 million and adjusted diluted EPS reached $0.60, surpassing consensus estimates.
2. Brand Segment Performance
The Hiya children’s wellness brand contributed a full year of revenue, while the Rise Wellness brand tripled its sales in 2025 as distribution expanded into key retail outlets. Net sales outside the core nutritional business rose to 16% of consolidated revenue from roughly 1% in 2024, supported by growth in mainland China, the United States and Canada.
3. 2026 Sales Guidance
Looking ahead, the company issued sales guidance of $925 million to $1.0 billion for fiscal 2026, reflecting expectations for continued momentum across its omnichannel and brand-driven segments.